Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Hidenori Toyoda & Takashi Kumada. (2009) Pharmacotherapy of chronic hepatitis C virus infection – the IDEAL trial: ‘2b or not 2b (= 2a), that is the question’. Expert Opinion on Pharmacotherapy 10:17, pages 2845-2857.
Read now
Read now
Articles from other publishers (26)
Robert Whittaker, Jørgen E Midtbø & Hilde Kløvstad. (2024) Monitoring Progress Towards the Elimination of Hepatitis C as a Public Health Threat in Norway: A Modelling Study Among People Who Inject Drugs and Immigrants. The Journal of Infectious Diseases.
Crossref
Crossref
Massimo Attanasio, Fabio Aiello & Fabio Tinè. (2023) A statistical method for removing unbalanced trials with multiple covariates in meta-analysis. PLOS ONE 18:12, pages e0295332.
Crossref
Crossref
Jamal Sarvari, Hossin Norozian, Mohamad Reza Fattahi, Neda Pirbonyeh & Afagh Moattari. (2014) The Role of Interferon Gamma Gene Polymorphism (+874A/T, +2109A/G, and -183G/T) in Response to Treatment Among Hepatitis C Infected Patients in Fars Province, Southern Iran. Hepatitis Monthly 14:1.
Crossref
Crossref
Ronald L Koretz, Maria Pleguezuelo, Vasiliki Arvaniti, Pilar Barrera Baena, Ruben Ciria, Kurinchi Selvan Gurusamy, Brian R Davidson & Andrew K Burroughs. (2013) Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Jesper Brok, Lise Lotte Gluud & Christian Gluud. (2010) Ribavirin plus interferon versus interferon for chronic hepatitis C. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Jesper Brok, Lise Lotte Gluud & Christian Gluud. (2009) Ribavirin monotherapy for chronic hepatitis C. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Michael S. Economou, Spyridon Filis, Helen Vienna, Dimitrios Christodoulou, Leonidas Christou & Epameinondas V. Tsianos. (2007) Treatment and retreatment in patients with chronic hepatitis C: 10 years clinical practice in a single centre. Liver International 27:3, pages 340-346.
Crossref
Crossref
Yousef S. KhaderAnmar Dweek, Ahmad Alkafajei & Atallah Z. Rabi'. (2016) Combination Therapy of Interferon and Ribavirin Versus Interferon Monotherapy in Treatment of Chronic Hepatitis C: A Meta-analysis of Clinical Trials. Journal of Pharmacy Practice 19:5, pages 265-274.
Crossref
Crossref
Furqaan Ahmed & Ira M. Jacobson. (2006) Treatment of Relapsers after Combination Therapy for Chronic Hepatitis C. Infectious Disease Clinics of North America 20:1, pages 137-153.
Crossref
Crossref
Ira M. Jacobson, Stevan A. Gonzalez, Furqaan Ahmed, Edward Lebovics, Albert D. Min, Henry C. Bodenheimer, Stephen P. Esposito, Robert S. Brown, Norbert Brau, Franklin M. Klion, Hillel Tobias, Edmund J. Bini, Neil Brodsky, Maurice A. Cerulli, Ayse Aytaman, Peter W. Gardner, Jane M. Geders, Julie E. Spivack, Michael G. Rahmin, David H. Berman, James Ehrlich, Mark W. Russo, Maxwell Chait, Deborah Rovner & Brian R. Edlin. (2005) A Randomized Trial of Pegylated Interferon alpha-2b Plus Ribavirin in the Retreatment of Chronic Hepatitis C. The American Journal of Gastroenterology 100:11, pages 2453-2462.
Crossref
Crossref
Jesper Brok, Lise Lotte Gluud & Christian Gluud. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Jesper Brok, Lise Lotte Gluud & Christian Gluud. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Olav Dalgard. (2005) Follow‐Up Studies of Treatment for Hepatitis C Virus Infection among Injection Drug Users. Clinical Infectious Diseases 40:s5, pages S336-S338.
Crossref
Crossref
G. Fattovich, I. Zagni, M. L. Ribero, E. Castagnetti, E. Minola, L. Lomonaco, C. Scattolini, P. Fabris, S. Boccia, M. Giusti, G. Abbati, M. Felder, P. Rovere, A. Redaelli, A. Tonon, A. Tomba, R. Montanari, C. Paternoster, M. Distasi, G. Fornaciari, G. Tositti, C. Rizzo, S. Suppressa, M. Pantalena, F. Noventa & A. Tagger. (2004) A randomized trial of prolonged high dose of interferon plus ribavirin for hepatitis C patients nonresponders to interferon alone. Journal of Viral Hepatitis 11:6, pages 543-551.
Crossref
Crossref
Furqaan Ahmed & Ira M. Jacobson. (2004) Treatment of relapsers after combination therapy for chronic hepatitis C. Gastroenterology Clinics of North America 33:3, pages 513-526.
Crossref
Crossref
Federica Benini, Luciana Distefano, Ornella Baisini, Marie Graciella Pigozzi & Alberto Lanzini. (2003) Efficacy and Tolerability of Combination Therapy with Interferon-Alfa Plus Ribavirin in Patients with Chronic Hepatitis C Virus Infection: A Single-Center Study in Relapsers and Nonresponders to Previous Treatment with High-Dose Interferon-Alfa Monotherapy. Current Therapeutic Research 64:3, pages 140-150.
Crossref
Crossref
Thierry Poynard & Robert P Myers. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
R. San Miguel, F. Guillén, J. M. Cabasés & M. Buti. (2002) Meta‐analysis: combination therapy with interferon‐α 2a/2b and ribavirin for patients with chronic hepatitis C previously non‐responsive to interferon. Alimentary Pharmacology & Therapeutics 16:9, pages 1611-1621.
Crossref
Crossref
C. H. Chang, K. Y. Chen, M. Y. Lai & K. A. Chan. (2002) Meta‐analysis: ribavirin‐induced haemolytic anaemia in patients with chronic hepatitis C. Alimentary Pharmacology & Therapeutics 16:9, pages 1623-1632.
Crossref
Crossref
Lise Lotte Gluud, Kim Krogsgaard & Christian Gluud. (2002) Ribavirin with or without alpha interferon for chronic hepatitis C. Cochrane Database of Systematic Reviews 2010:1.
Crossref
Crossref
O. Dalgard, K. Bjøro, K. Hellum, B. Myrvang, K. Skaug, B. Gutigard & H. Bell. (2002) Treatment of Chronic Hepatitis C in Injecting Drug Users: 5 Years’ Follow-Up. European Addiction Research 8:1, pages 45-49.
Crossref
Crossref
J.A. Moreno Monteagudo, L. García Buey, M. Trapero Marugán & R. Moreno Otero. (2002) Tratamiento antivírico de la hepatitis crónica C en pacientes no respondedores al interferón. Gastroenterología y Hepatología 25:5, pages 342-346.
Crossref
Crossref
Vincent G. Bain. (2001) Effect of HCV viral dynamics on treatment design: lessons learned from HIV. The American Journal of Gastroenterology 96:10, pages 2818-2828.
Crossref
Crossref
V. Di Marco, A. Vaccaro, D. Ferraro, G. Alaimo, V. Rodolico, P. Parisi, S. Peralta, R. Di Stefano, P. L. Almasio & A. Craxì. (2002) High‐dose prolonged combination therapy in non‐responders to interferon monotherapy for chronic hepatitis C. Alimentary Pharmacology & Therapeutics 15:7, pages 953-958.
Crossref
Crossref
Peter Ferenci, Rudolf Stauber, Petra Steindl-Munda, Michael Gschwantler, Peter Fickert, Christian Datz, Christian Müller, Franz Hackl, Wolfgang Rainer, Thomas Watkins-Riedel, Werner Lin, Günter J. Krejs & Alfred Gangl. (2001) Treatment of patients with chronic hepatitis C not responding to interferon with high-dose interferon alpha with or without ribavirin: final results of a prospective randomized trial. European Journal of Gastroenterology & Hepatology 13:6, pages 699-705.
Crossref
Crossref
Gary L. Davis. (2000) Current therapy for chronic hepatitis C. Gastroenterology 118:2, pages S104-S114.
Crossref
Crossref